Business
The global pharmaceutical industry is facing some difficult strategic choices. As the costs of Research and Development rise, other more reliable revenue streams look increasingly attractive. In this edition of Global Business Peter Day hears from three leading industry insiders who share their visions for the future of the pharma business, discuss the focus on emerging healthcare models and tell him how the industry will find investment over the coming years. Producer: Julie Ball Editor: Stephen Chilcott
More Episodes
The Business of Food Waste
2017-09-28
66
2017-09-28
66
Playing the Market
2017-09-21
50
2017-09-21
50
Crossing the Line
2017-09-14
45
2017-09-14
45
Private Prisons: Who Profits?
2017-08-19
24
2017-08-19
24
The Secrets of Germany's Success
2017-08-11
63
2017-08-11
63
Community Enterprise
2017-08-11
20
2017-08-11
20
Fish to Share
2017-08-05
5
2017-08-05
5
Managing a Tower Block
2017-08-03
12
2017-08-03
12
Forecasting: How to Map the Future
2017-07-24
30
2017-07-24
30
India's Cashless Economy
2017-05-30
23
2017-05-30
23
Engineering the Future
2017-05-28
10
2017-05-28
10
Keeping Up with the Burgers
2017-05-19
1
2017-05-19
1
The Art of the Meeting
2017-05-12
18
2017-05-12
18
Rebooting Rural Russia
2017-05-06
2
2017-05-06
2
The Big Fat Greek Struggle
2017-04-29
5
2017-04-29
5
From Ex-Offender to Entrepreneur
2017-04-22
10
2017-04-22
10
In Business: Northern Ireland and Brexit
2017-04-15
11
2017-04-15
11
In Business: Why are the French so productive?
2017-04-08
21
2017-04-08
21
Mexican remittances on the rise
2017-04-01
1
2017-04-01
1
Denmark's Wind Power Progress
2017-03-25
3
2017-03-25
3
Get this podcast on your
phone, FREE
